These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34396370)

  • 1. Hematopoietic JAK2
    Sano S; Walsh K
    J Cardiovasc Aging; 2021; 1():. PubMed ID: 34396370
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Sano S; Wang Y; Yura Y; Sano M; Oshima K; Yang Y; Katanasaka Y; Min KD; Matsuura S; Ravid K; Mohi G; Walsh K
    JACC Basic Transl Sci; 2019 Oct; 4(6):684-697. PubMed ID: 31709318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.
    Hinds DA; Barnholt KE; Mesa RA; Kiefer AK; Do CB; Eriksson N; Mountain JL; Francke U; Tung JY; Nguyen HM; Zhang H; Gojenola L; Zehnder JL; Gotlib J
    Blood; 2016 Aug; 128(8):1121-8. PubMed ID: 27365426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease burden at the progenitor level is a feature of primary myelofibrosis: a multivariable analysis of 164 JAK2 V617F-positive myeloproliferative neoplasm patients.
    Stein BL; Williams DM; Rogers O; Isaacs MA; Spivak JL; Moliterno AR
    Exp Hematol; 2011 Jan; 39(1):95-101. PubMed ID: 20888389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.
    Fidler TP; Xue C; Yalcinkaya M; Hardaway B; Abramowicz S; Xiao T; Liu W; Thomas DG; Hajebrahimi MA; Pircher J; Silvestre-Roig C; Kotini AG; Luchsinger LL; Wei Y; Westerterp M; Snoeck HW; Papapetrou EP; Schulz C; Massberg S; Soehnlein O; Ebert B; Levine RL; Reilly MP; Libby P; Wang N; Tall AR
    Nature; 2021 Apr; 592(7853):296-301. PubMed ID: 33731931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycythemia vera: scientific advances and current practice.
    Tefferi A; Spivak JL
    Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.
    Rai S; Zhang Y; Grockowiak E; Kimmerlin Q; Hansen N; Stoll CB; Usart M; Luque Paz D; Hao-Shen H; Zhu Y; Roux J; Bader MS; Dirnhofer S; Farady CJ; Schroeder T; Méndez-Ferrer S; Skoda RC
    Blood Adv; 2024 Mar; 8(5):1234-1249. PubMed ID: 38207211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.
    Kralovics R; Teo SS; Li S; Theocharides A; Buser AS; Tichelli A; Skoda RC
    Blood; 2006 Aug; 108(4):1377-80. PubMed ID: 16675710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders.
    Hsieh PP; Olsen RJ; O'Malley DP; Konoplev SN; Hussong JW; Dunphy CH; Perkins SL; Cheng L; Lin P; Chang CC
    Mod Pathol; 2007 Sep; 20(9):929-35. PubMed ID: 17643100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation.
    Perner F; Perner C; Ernst T; Heidel FH
    Cells; 2019 Aug; 8(8):. PubMed ID: 31398915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The JAK-STAT pathway and hematopoietic stem cells from the JAK2 V617F perspective.
    Staerk J; Constantinescu SN
    JAKSTAT; 2012 Jul; 1(3):184-90. PubMed ID: 24058768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK2
    Lin CH; Kaushansky K; Zhan H
    Blood Cells Mol Dis; 2016 Nov; 62():42-48. PubMed ID: 27865175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
    Bellucci S; Michiels JJ
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2
    Wang W; Liu W; Fidler T; Wang Y; Tang Y; Woods B; Welch C; Cai B; Silvestre-Roig C; Ai D; Yang YG; Hidalgo A; Soehnlein O; Tabas I; Levine RL; Tall AR; Wang N
    Circ Res; 2018 Nov; 123(11):e35-e47. PubMed ID: 30571460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα.
    Hasan S; Lacout C; Marty C; Cuingnet M; Solary E; Vainchenker W; Villeval JL
    Blood; 2013 Aug; 122(8):1464-77. PubMed ID: 23863895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Somatic mutation of the V617F JAK2 gene in patients of the cardiovascular diseases].
    Olkhovskiy IA; Gorbenko AS; Stolyar MA; Grischenko DA; Tkachenko OA; Martsinkevich TL
    Ter Arkh; 2019 Jul; 91(7):25-28. PubMed ID: 32598732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycythemia vera is not initiated by JAK2V617F mutation.
    Nussenzveig RH; Swierczek SI; Jelinek J; Gaikwad A; Liu E; Verstovsek S; Prchal JF; Prchal JT
    Exp Hematol; 2007 Jan; 35(1):32-8. PubMed ID: 17198871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders.
    Rumi E; Passamonti F; Pietra D; Della Porta MG; Arcaini L; Boggi S; Elena C; Boveri E; Pascutto C; Lazzarino M; Cazzola M
    Cancer; 2006 Nov; 107(9):2206-11. PubMed ID: 16998940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK2-V617F-mutated myeloproliferative neoplasms reveal different allele burden within hematopoietic cell lineages: a microdissection study of bone marrow trephine biopsies.
    Kreft A; Kindler T; Springer E; Kirkpatrick CJ
    Virchows Arch; 2011 Nov; 459(5):521-7. PubMed ID: 22006129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens.
    Moliterno AR; Williams DM; Rogers O; Isaacs MA; Spivak JL
    Exp Hematol; 2008 Nov; 36(11):1480-6. PubMed ID: 18723264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.